SCHEMBL153229

SCHEMBL153229

FC(F)C1CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29307180 0.81 CHRM2 (0.34)
SCHEMBL29307177 0.76
SCHEMBL29306903 0.74
SCHEMBL16993605 0.74
SCHEMBL15444045 0.73
SCHEMBL15444052 0.73
SCHEMBL25192773 0.72
SCHEMBL10070496 0.72
SCHEMBL10357560 0.72
SCHEMBL2547285 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180312483-A1 Method for Industrial Production of Optically Active Fluoroalkyl Ethylene Oxide CENTRAL GLASS COMPANY, LIMITED (JP) 2018-11-01 US claimed
EP-2296581-B1 A BIOMATERIAL COLOPLAST AS (DK) 2017-11-15 EP claimed
US-7932343-B2 Biomaterial VYSERA BIOMEDICAL LIMITED (IE) 2011-04-26 US claimed
US-20250370170-A1 TUNABLE LENS WITH FLUID-FILLED CHAMBERS COMPRISING DIFFERENT MATERIALS APPLE INC (US) 2025-12-04 US disclosed
US-12440323-B2 Method of delivering a urological device into a bladder neck or urethra of a user COLOPLAST A/S (DK) 2025-10-14 US disclosed
CN-116462654-B Preparation method of cyclic ethylene carbonate compound 上海如鲲新材料股份有限公司 2025-06-10 CN disclosed
EP-3308822-B1 A UROLOGICAL DEVICE COLOPLAST AS (DK) 2024-12-11 EP disclosed
WO-2024059169-A1 EGFR INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2024-03-21 WO disclosed
US-11718618-B2 Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors NEUROCRINE BIOSCIENCES, INC. (US) 2023-08-08 US disclosed
US-11718618-B2 Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors NEUROCRINE BIOSCIENCES, INC. (US) 2023-08-08 US disclosed
US-11710854-B2 Functional epoxides in catalyst-based electrolyte compositions for Li-ion batteries ENEVATE CORPORATION (US) 2023-07-25 US disclosed
EP-2296581-A1 A BIOMATERIAL Vysera Biomedical Limited (IE) 2011-03-23 EP disclosed
US-20100137998-A1 ESOPHAGEAL VALVE VYSERA BIOMEDICAL LIMITED (IE) 2010-06-03 US disclosed
US-20100120934-A1 BIOMATERIAL VYSERA BIOMEDICAL LIMITED (IE) 2010-05-13 US disclosed
US-20100121462-A1 VALVE VYSERA BIOMEDICAL LIMITED (IE) 2010-05-13 US disclosed
US-20100121461-A1 VALVE VYSERA BIOMEDICAL LIMITED (IE) 2010-05-13 US disclosed
WO-2009153769-A1 A BIOMATERIAL VYSERA BIOMEDICAL LIMITED (IE) 2009-12-23 WO disclosed
WO-2009153770-A1 ESOPHAGEAL VALVE VYSERA BIOMEDICAL LIMITED (IE) 2009-12-23 WO disclosed
WO-2009153771-A1 ESOPHAGEAL VALVE VYSERA BIOMEDICAL LIMITED (IE) 2009-12-23 WO disclosed
WO-2009153768-A1 ESOPHAGEAL VALVE VYSΕRA BIOMEDICAL LIMITED (IE) 2009-12-23 WO disclosed